Concentra Group Holdings Parent, Inc.

NYSE:CON

Medical - Equipment & Services

Healthcare
$41.98 +0.53%

+$0.15 today

Market cap
$5.31B
Beta
0.82
P/E (TTM)
20.3
EPS (TTM)
$1.41
Dividend yield
0.88%
52W Low $18.55High $28.94

Volume 0.74M

Average 0.90M

CON Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Concentra Group Holdings Parent, Inc.NYSE: CON

Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026

Accounts receivables growth accelerates

Q3 FY2026 accounts receivables of $20.5M (cash outflow) rose 169.9% year over year, ahead of the +47.8% change in trailing-twelve-month accounts receivables. Sequentially, it rose 512.2% from the prior quarter. Over 3 fiscal years it compounded at +23.4% a year.

Context

  • Accounts receivables amounted to 0.5% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Accounts receivables grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +169.9% holds above the trailing-twelve-month pace of +47.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$20.5M+512.2% QoQ
Last fiscal yearDec 2025
-$11.14M+596.9% YoY
LTMSep 2026
-$28.63M+47.8% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+169.9%——
1 year+596.9%——
3-year CAGR+23.4%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(11.14M) USD
Year-over-year change
-596.9%

Accounts Receivables vs competitors

How CON compares with its peers on the latest reported figures

  • CON's LTM Sep 2026 accounts receivables of $28.63M is the 4th largest of the 10 companies compared; the peer median is $18.14M.
  • Its year-over-year change of +47.8% is the 3rd highest of 9, against a peer median of -40.5%.
  • Accounts receivables amounts to 1.2% of revenue for CON, versus a peer median of 1.3%.
CON Competitors Peer median
Accounts Receivables for CON and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$73.72M +19.1%+33.7%0.7%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$59.57M +453.0%+151.8%10.0%
ITGRInteger Holdings CorporationLTM Jul 2026$49.25M +31.2%+29.4%2.7%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$28.63M +47.8%+23.4%1.2%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$27.58M -693.3%-47.1%2.5%
HAEHaemonetics CorporationLTM Jun 2026$18.14M -813.4%-15.2%1.3%
ADUSAddus HomeCare CorporationLTM Jun 2026$9.98M -1289.6%—0.7%
HCMHUTCHMED (China) LimitedLTM Jun 2025$9.93M +133.2%—1.6%
BEAMBeam Therapeutics Inc.LTM Jun 2026$0 ——0.0%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$0 -100.0%—0.0%
Peer median (excluding CON) $18.14M-40.5%+29.4%1.3%

Competitors are the stored peer set for CON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income216.04M172.24M184.74M171.9M172.8M
Depreciation & Amortization82.21M73.67M73.05M67.18M75.82M
Deferred Income Tax(1.33M)(8.64M)(6.29M)(2.4M)0
Stock-Based Compensation2.14M2.14M651K2.33M0
Change in Working Capital(7.28M)33.92M(18.7M)30.18M7.96M
Accounts Receivables12.52M(5.93M)(10.26M)(1.6M)(11.14M)
Inventory00000
Accounts Payables00024.59M17.97M
Other Working Capital(19.8M)39.85M(8.44M)7.18M1.13M
Other Non-Cash Items(1.14M)1.01M857K5.5M22.82M
Operating Cash Flow290.64M274.34M234.32M274.68M279.4M
Capital Expenditures(46.79M)(45.98M)(69.34M)(64.33M)(82.34M)
Acquisitions (Net)(20.1M)(11.81M)(6M)(6.97M)0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities5.09M38K36K27K(414.86M)
Investing Cash Flow(61.8M)(57.75M)(75.31M)(71.27M)(414.86M)
Debt Repayment(326.89M)(184.68M)(161.69M)999.95M90.39M
Common Stock Issued10.13M3.34M3.34M511.2M0
Common Stock Repurchased0(29.05M)(5.32M)(15.4M)(22.42M)
Dividends Paid00(6.13M)(1.54B)(32.08M)
Other Financing Activities(25.82M)534K4.52M(3.63M)(3.78M)
Financing Cash Flow(342.59M)(209.86M)(165.29M)(51.53M)32.1M
Effect of Forex Changes00000
Net Change in Cash(113.75M)6.73M(6.28M)151.88M(103.36M)
Free Cash Flow243.85M228.35M164.98M210.35M197.06M

Concentra Group Holdings Parent, Inc.

NYSE:CON

Intrinsic Alpha fair value

Locked

Current Price

$41.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.